Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients.

Lokeshwar VB, Morera DS, Hasanali SL, Yates TJ, Hupe MC, Knapp J, Lokeshwar SD, Wang J, Hennig MJ, Baskar R, Escudero DO, Racine RR, Dhir N, Jordan AR, Hoye K, Azih I, Manoharan M, Klaassen Z, Kavuri S, Lopez LE, Ghosh S, Lokeshwar BL.

Clin Cancer Res. 2020 Feb 24. pii: clincanres.2912.2019. doi: 10.1158/1078-0432.CCR-19-2912. [Epub ahead of print]

PMID:
32094233
2.

Pre-clinical to clinical translational failures and current status of clinical trials in stroke therapy: a brief review.

Dhir N, Medhi B, Prakash A, Goyal MK, Modi M, Mohindra S.

Curr Neuropharmacol. 2020 Jan 14. doi: 10.2174/1570159X18666200114160844. [Epub ahead of print]

PMID:
31934841
3.

Straight-to-test for the two-week-wait colorectal cancer pathway under the updated NICE guidelines reduces time to cancer diagnosis and treatment.

Christopher J, Flint TR, Ahmed H, Dhir N, Li R, Macfarland K, Ng D, Ng J, O'Neill C, Te Water Naudé A, Sloan K, Hall NR, Powar MP.

Ann R Coll Surg Engl. 2019 May;101(5):333-339. doi: 10.1308/rcsann.2019.0022.

PMID:
31042431
4.

Improved activity recognition via Kalman smoothing and multiclass linear discriminant analysis.

Dhir N, Wood F.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:582-5. doi: 10.1109/EMBC.2014.6943658.

PMID:
25570026
5.

Chronic myeloid leukemia as a second malignant neoplasm in a patient with medulloblastoma after treatment with chemotherapy and irradiation: a case report and review of the literature.

Dhir N, Zaky W, Zomorodian T, Dhall G.

Pediatr Hematol Oncol. 2013 Feb;30(1):28-9. doi: 10.3109/08880018.2012.748856. Epub 2012 Dec 28. Review. No abstract available.

PMID:
23273112
6.

Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.

Lokeshwar VB, Lopez LE, Munoz D, Chi A, Shirodkar SP, Lokeshwar SD, Escudero DO, Dhir N, Altman N.

Cancer Res. 2010 Apr 1;70(7):2613-23. doi: 10.1158/0008-5472.CAN-09-3185. Epub 2010 Mar 23.

7.

Liquid nitrogen ingestion followed by gastric perforation.

Berrizbeitia LD, Calello DP, Dhir N, O'Reilly C, Marcus S.

Pediatr Emerg Care. 2010 Jan;26(1):48-50. doi: 10.1097/PEC.0b013e3181cd14b3.

PMID:
20065833
8.

Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis.

Bishayee A, Dhir N.

Chem Biol Interact. 2009 May 15;179(2-3):131-44. doi: 10.1016/j.cbi.2008.11.015. Epub 2008 Nov 27.

PMID:
19073162
9.

Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoter.

Lokeshwar VB, Gomez P, Kramer M, Knapp J, McCornack MA, Lopez LE, Fregien N, Dhir N, Scherer S, Klumpp DJ, Manoharan M, Soloway MS, Lokeshwar BL.

J Biol Chem. 2008 Oct 24;283(43):29215-27. doi: 10.1074/jbc.M801101200. Epub 2008 Aug 21.

10.

How Helicobacter pylori urease may affect external pH and influence growth and motility in the mucus environment: evidence from in-vitro studies.

Sidebotham RL, Worku ML, Karim QN, Dhir NK, Baron JH.

Eur J Gastroenterol Hepatol. 2003 Apr;15(4):395-401.

PMID:
12655260
11.

Changes to mucins in uninvolved mucosa and at the tumour site in gastric adenocarcinoma of intestinal type.

Sidebotham RL, Dhir NK, Elder JB, Spencer J, Walker MM, Schrager J.

Clin Sci (Lond). 1998 Jan;94(1):87-99. Erratum in: Clin Sci (Colch) 1998 Mar;94(3):333.

PMID:
9505871
12.

Pepsin and the gastric mucus barrier.

Sidebotham RL, Batten JJ, Dhir NK, Baron JH.

Dig Dis Sci. 1990 Oct;35(10):1305-7. No abstract available.

PMID:
2209297

Supplemental Content

Support Center